COMP <GO>
CI vs HUM // EV/EBITDA & P/E VALUATION
The Cigna Group (NYSE) VS. Humana Inc. (NYSE) • 15-METRIC TALLY: CI 10
— HUM 3
▲ EV/EBITDA & P/E VALUATION LEADER: CI
LAST: $298.23 (-0.06%) • MKT CAP: $78.85B
valuation
6.1x
LAST: $414.50 (-0.73%) • MKT CAP: $50.14B
valuation
18.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CI VS. HUM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CI | HUM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | 8.30% | +0.50 | CI | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.1x | 18.4x | -12.30 | CI | /valuation <GO> |
| Free Cash Flow Yield | -3.51% | 0.75% | -4.26 | HUM | /fcf-yield <GO> |
| Operating Margin | 3.30% | 2.10% | +1.20 | CI | /operating-margins <GO> |
| Net Profit Margin | 2.20% | 0.90% | +1.30 | CI | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 10.10% | +1.10 | CI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.04% | 0.86% | +1.18 | CI | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.70 | 5.03 | -2.33 | HUM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | HUM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.8 | 53.9 | +1.90 | CI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.12 | 0.88 | +0.24 | CI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.3x | 39.2x | -26.90 | CI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $78.85B | $50.14B | $28.71B | CI | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CI REV | HUM REV | CI GROSS % | HUM GROSS % | CI FCF | HUM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $274.90B | $129.66B | 21.8% | — | -$2.77B | $375.0M |
| FY 2024 | $247.12B | $117.76B | 26.1% | — | -$757.4M | $2.39B |
| FY 2023 | $195.26B | $106.37B | — | — | $3.03B | -$805.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CI // BETA 1.12
HUM // BETA 0.88